Wang, G., Huang, M., Jiang, L., Zhang, X., Wang, Z., Yu, Q., . . . Cao, Y. (2025). Be cautious to adopt a second CAR T-cell infusion after failure of CD19/CD22 cocktail CAR T-cell therapy in relapsed/refractory B-NHL. Cancer Immunology, Immunotherapy : CII, 74(5), 156-10. https://doi.org/10.1007/s00262-025-04001-7
Chicago-Zitierstil (17. Ausg.)Wang, Gaoxiang, et al. "Be Cautious to Adopt a Second CAR T-cell Infusion After Failure of CD19/CD22 Cocktail CAR T-cell Therapy in Relapsed/refractory B-NHL." Cancer Immunology, Immunotherapy : CII 74, no. 5 (2025): 156-10. https://doi.org/10.1007/s00262-025-04001-7.
MLA-Zitierstil (9. Ausg.)Wang, Gaoxiang, et al. "Be Cautious to Adopt a Second CAR T-cell Infusion After Failure of CD19/CD22 Cocktail CAR T-cell Therapy in Relapsed/refractory B-NHL." Cancer Immunology, Immunotherapy : CII, vol. 74, no. 5, 2025, pp. 156-10, https://doi.org/10.1007/s00262-025-04001-7.